CHEMBIO DIAGNOSTICS, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2010-12-01: Form 8-K; Period of report 2010-12-01; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2010-11-29: Form 8-K; Period of report 2010-11-29; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2010-11-04: Form 8-K; Period of report 2010-11-04; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2010-10-25: Form 8-K; Period of report 2010-10-25; Description 7.01 Regulation FD Disclosure; Details 7.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2010-12-01 | 8-K | 2010-12-01 | 7.01 Regulation FD Disclosure | 7.01 On November 30, 2010, the Company issued a press release entitled “Chembio & Fiocruz enter into DPP® Syphilis Technology Transfer Agreement”. | form8_k.htm |
| 2010-11-29 | 8-K | 2010-11-29 | 7.01 Regulation FD Disclosure | 7.01 On November 29, 2010, the Company posted a PowerPoint Presentation entitled “Investor Presentation December 2010” to its website. | form8_k.htm |
| 2010-11-04 | 8-K | 2010-11-04 | 7.01 Regulation FD Disclosure | 7.01 On November 2, 2010, the Company issued a press release entitled “Chembio Awarded $1.467 Million under Health Care Reform Program”. | form8_k.htm |
| 2010-10-25 | 8-K | 2010-10-25 | 7.01 Regulation FD Disclosure | 7.01 On October 25, 2010, the Company posted a PowerPoint Presentation entitled “Investor Presentation October 2010” to their website. | form8k.htm |
| 2010-09-24 | 8-K | 2010-09-23 | 7.01 Regulation FD Disclosure | 7.01 On September 23, 2010, the Company issued a press release entitled “FIOCRUZ Receives Regulatory Approval to Market Chembio DPP® HIV 1/2 Confirmatory Test in Brazil” dated September 23, 2010. | form8_k.htm |
| 2010-08-05 | 8-K | 2010-08-05 | 7.01 Regulation FD Disclosure | 7.01 On August 4, 2010, the Company posted a PowerPoint Presentation entitled “Investor Presentation” to their website. | form8_k.htm |
| 2010-07-29 | 8-K | 2010-07-29 | 7.01 Regulation FD Disclosure | 7.01 On July 29, 2010, the Company issued a press release entitled “Chembio Reports Second Quarter 2010 Results”. | form8_k.htm |
| 2010-07-22 | 8-K | 2010-07-22 | 7.01 Regulation FD Disclosure | 7.01 On July 21, 2010, the Company issued a press release entitled “Chembio to Host Conference Call to Discuss Second Quarter 2010 Financial Results”. | form8_k.htm |
| 2010-06-30 | 8-K | 2010-06-30 | 7.01 Regulation FD Disclosure | 7.01 On June 28, 2010, Bio-Manguinhos, a division of the Oswaldo Cruz Foundation of Brazil (“FIOCRUZ”), notified the Company that it had received regulatory approval from Brazil’s National Health Surveillance Agency (Anvisa) to market Chembio’s Dual Path Platform (DPP®) HIV 1/2 rapid test for use with oral fluid, blood, serum or plasma samples . | form8_k.htm |
| 2010-06-29 | 8-K | 2010-06-29 | 7.01 Regulation FD Disclosure | 7.01 On June 25, 2010, the Company received a letter from Bio-Rad Laboratories (“Bio-Rad”), confirming the completion of Phase 2 (the Development Phase) of the Exclusive Development Agreement signed in April 2008 for a multiplex product employing Chembio’s patented DPP® technology (the “Product”). | form8_k.htm |
| 2010-06-17 | 8-K | 2010-06-17 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 The information provided in Item 2.03 below hereby is incorporated by reference into this Item 1.01. 2.03 On June 14, 2010, Chembio Diagnostic Systems, Inc., the wholly-owned subsidiary of Chembio Diagnostics, Inc. (collectively the “Company”), entered into three agreements with HSBC Bank, NA (“HSBC”). | form8_k.htm |
| 2010-06-02 | 8-K | 2010-06-02 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 At the Company’s annual stockholder meeting on June 2, 2010, stockholders elected directors of the Company to serve until the next annual meeting of stockholders or until their respective successors are elected and qualified. | form8_k.htm |
| 2010-06-02 | 8-K | 2010-06-02 | 7.01 Regulation FD Disclosure | 7.01 On June 2, 2010, the Company presented at their Annual Shareholder’s Meeting a PowerPoint Presentation entitled “Annual Shareholders Meeting”. | form8_k.htm |
| 2010-05-10 | 8-K | 2010-05-10 | 7.01 Regulation FD Disclosure | 7.01 On May 10, 2010, the Company issued a press release entitled “Chembio to Sponsor AIDS Walk New York 2010”. | form8_k.htm |
| 2010-05-06 | 8-K | 2010-05-06 | 7.01 Regulation FD Disclosure | 7.01 On May 6, 2010, the Company issued a press release entitled “Chembio Reports First Quarter 2010 Results”. | form8_k.htm |
| 2010-04-29 | 8-K | 2010-04-29 | 7.01 Regulation FD Disclosure | 7.01 On April 29, 2010, the Company issued a press release entitled “Chembio to Host Conference Call to Discuss First Quarter 2010 Financial Results”. | form8k.htm |
| 2010-04-22 | 8-K | 2010-04-22 | 7.01 Regulation FD Disclosure | 7.01 On April 22, 2010, the Company posted a PowerPoint Presentation to their website entitled “Investor Presentation”. | form8_k.htm |
| 2010-03-25 | 8-K | 2010-03-25 | 7.01 Regulation FD Disclosure | 7.01 On March 24, 2010, the Company issued a press release entitled “Chembio’s DPP® Oral Fluid HIV Test Approved by USAID”. | form8k.htm |
| 2010-03-11 | 8-K | 2010-03-11 | 1.01 Entry into a Material Definitive Agreement; 3.03 Material Modification to Rights of Security Holders | 1.01 Entry into a Material Definitive Agreement. 3.03 Issuance of Rights for outstanding Common Stock. | form8_k.htm |
| 2010-03-05 | 8-K | 2010-03-05 | 7.01 Regulation FD Disclosure | 7.01 On March 5, 2010, the Company issued a press release entitled “Chembio Reports 2009 Results”. | form8_k.htm |
| 2010-02-23 | 8-K | 2010-02-23 | 7.01 Regulation FD Disclosure | 7.01 On February 23, 2010, the Company issued a press release entitled “Chembio to Host Conference Call to Discuss 2009 Financial Results” . | form8k.htm |